Loading clinical trials...
Loading clinical trials...
Deep Versus Moderate Neuromuscular Blockade in Bariatric Surgery:
The aim of this study is to investigate the effect of depth of neuromuscular blockade on the surgical field, patient postoperative pain, intestinal motility, the incidence of postoperative nausea and vomiting and the effect of deep versus moderate neuromuscular blockade on postoperative atelectasis quantitatively using chest computed tomography.This is a prospective, randomized, controlled clinical-controlled study in patients ≥18 years old scheduled to undergo elective bariatric surgery.
Age
18 - 65 years
Sex
ALL
Healthy Volunteers
No
Start Date
August 1, 2024
Primary Completion Date
August 1, 2026
Completion Date
August 1, 2026
Last Updated
August 14, 2024
50
ESTIMATED participants
Deep neuromascular blockage
DRUG
Moderate neuromascular blockage
DRUG
Lead Sponsor
University Hospital of Patras
NCT07404579
NCT06409260
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06794450